ARAY - Accuray launches CyberKnife platform in Africa for cancer patients
- Accuray ( NASDAQ: ARAY ) said it had launched its CyberKnife platform in Africa for more patients to receive treatments with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) the system delivers.
- CyberKnife platform can treat certain neurologic conditions and a wide range of tumor types throughout the body, and at various stages of disease.
- The entire CyberKnife procedure is typically completed in just 1 to 5 out-patient sessions, providing a shorter overall course of treatment compared to conventional radiation therapy which typically takes 30-40 sessions.
For further details see:
Accuray launches CyberKnife platform in Africa for cancer patients